Related Experiment Video
Updated: Mar 17, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Missing Value Estimation for Compound-Target Activity Data
Yusuf Tanrikulu1, Rama Kondru2, Gisbert Schneider3
1Pharma Research & Early Development Informatics, Hoffmann-La Roche Inc. 340 Kingsland Street, Nutley, NJ 07110, USA phone/fax: +1-973-235-6834/-8531. yusuf.tanrikulu@roche.com.
Abstract:
Relationships between drug targets and associated diseases have traditionally been investigated by means of sequence similarity, comparative protein modeling, and pathway analysis. Recently, a complementary paradigm has emerged to link targets and drugs via biological responses within activity data and visualize findings in networks. It has been indicated that one of the obstacles towards the identification of novel interactions is the sparsity of available data. In this article, we provide a survey of estimation methods that address the challenge of data sparsity. Each method is described in terms of its advantages and limitations, and an exemplary application on compound-target activity data is demonstrated. With such imputation methods in-hand, the opportunity to combine efforts in molecular informatics can be realized, yielding novel insights into ligand-target space.
More Related Videos
Related Concept Videos
Mechanistic Models: Compartment Models in Individual and Population Analysis
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Estimation of k and VD of Aminoglycosides
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Quantifying and Rejecting Outliers: The Grubbs Test
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...

